ESR1 and hepatocellular carcinoma: As noted previously, our most recent study demonstrated that estrogen can down-regulate ERα-36 expression and activate the AKT/Foxo3a signaling axis, triggering oxidative stress and ultimately apoptosis in HCC cells (Figure 6).